Cannabis Edibles and Alcohol Interaction: Clinical Evidence for Safe Dosing in Family Medicine
Table of Contents
- #8 Impact of Cannabis Edibles Combined With Alcohol on Driving, Field Sobriety Performance, and Subjective Effects: A Within-Participant Crossover Trial.
- What This Study Teaches Us
- Why This Matters Clinically
- Study Snapshot
- Where This Paper Deserves Skepticism
- Dr. Caplan’s Take
- Clinical Bottom Line
- Read next
Clinical Takeaway
Combining cannabis edibles with alcohol produces greater driving impairment than either substance alone, as measured by simulated driving performance and field sobriety testing. The delayed onset of edible cannabis means impairment may peak unpredictably relative to alcohol intoxication, making the combined risk difficult for users to self-assess. Individuals who consume both substances should not drive, regardless of how they feel in the moment.
#8 Impact of Cannabis Edibles Combined With Alcohol on Driving, Field Sobriety Performance, and Subjective Effects: A Within-Participant Crossover Trial.
Citation: Zamarripa C Austin et al.. Impact of Cannabis Edibles Combined With Alcohol on Driving, Field Sobriety Performance, and Subjective Effects: A Within-Participant Crossover Trial.. JAMA network open. 2026. PMID: 42065887.
Want to apply this research to your care?
CED Clinic translates emerging research into individualized clinical care. Dr. Caplan has treated 30,000+ patients.
Book a consultation →Design: 5 Journal: 4 N: 0 Recency: 3 Pop: 1 Human: 1 Risk: -2
- Preclinical only
Abstract: IMPORTANCE: Simultaneous cannabis and alcohol use (co-use) is a public safety concern. Controlled data on the effects of co-ingestion of oral cannabis products (edibles) with alcohol are lacking, despite an increased prevalence of this behavior. OBJECTIVE: To evaluate the individual and interactive effects of cannabis edibles and alcohol on simulated driving and subjective and objective impairment measures. DESIGN, SETTING, AND PARTICIPANTS: This within-participant, double-blind, double-dummy crossover study of healthy adults included 7 outpatient sessions, separated by 1 week, at Johns Hopkins University School of Medicine from February 2022 to August 2025. INTERVENTION: Brownies containing 0 mg, 10 mg, or 25 mg Δ9-tetrahydrocannabinol (THC) combined with placebo drinks or alcohol-containing drinks, calculated to achieve breath alcohol concentrations (BrACs) of 0%, 0.05%, or 0.08%. MAIN OUTCOMES AND MEASURES: Driving outcomes included the global drive score (GDS), a composite index of multiple driving measures, and the standard deviation of lateral position as the main outcomes. Other outcomes included cumulative impairment clues on standardized field sobriety tests (SFSTs), subjective drug effects, cognitive and psychomotor performance (using the DRUID [Driving Under the Influence of Drugs] application), and blood cannabinoid concentrations. RESULTS: Participants included 25 healthy adults (15 males [60%]; mean [SD] age, 25.6 [4.9] years) who reported recent binge drinking, prior cannabis and alcohol co-use, and fewer than 3 cannabis uses per week. Compared with placebo, all active drug conditions except 10 mg THC negatively impacted driving performance (ie, GDS). Driving impairment from alcohol alone at 0.08% BrAC was comparable with that of 0.05% BrAC and 10 mg THC (mean [SD] GDS, 1.6 [1.6] vs 1.6 [1.4]) and significantly lower than 0.05% BrAC and 25 mg THC (mean [SD] GDS, 2.5 [1.7]; P = .02). Driving impairment and subjective intoxication (eg, confidence to dri
What This Study Teaches Us
Moderate alcohol (0.08% BAC) alone impairs driving similarly to 10 mg THC, but higher THC doses (25 mg) and combinations of THC with alcohol produce additive or greater impairment on simulated driving tasks. This is among the first controlled data on how edible cannabis and alcohol interact in ways that matter for real-world safety.
Why This Matters Clinically
Clinicians need clear language when counseling patients about co-use risks, and this fills a gap where controlled evidence was nearly absent. Patients combining cannabis edibles with drinking represent a growing real-world behavior with genuine public safety implications, making this relevant to primary care conversations about substance use.
Study Snapshot
| Study Design | Within-participant double-blind double-dummy randomized crossover trial with 7 sessions separated by 1 week |
| Population | 25 healthy adults (60% male, mean age 25.6 years) with recent binge drinking history, prior cannabis-alcohol co-use, and fewer than 3 cannabis uses per week |
| Intervention | Brownies containing 0, 10, or 25 mg THC combined with placebo or alcohol-containing drinks targeting 0%, 0.05%, or 0.08% breath alcohol concentration |
| Primary Outcome | Global drive score (composite index of multiple driving measures) and standard deviation of lateral position on simulated driving task |
| Key Result | All active drug conditions except 10 mg THC alone negatively impacted driving. Driving impairment from 0.08% BAC alcohol alone was comparable to 10 mg THC; higher THC or combinations showed greater impairment |
Where This Paper Deserves Skepticism
The sample is small (N=25) and skewed toward young, healthy adults with recent binge drinking and cannabis co-use experience, limiting generalizability to older or cannabis-naive populations. The abstract doesn’t specify the full interaction results between alcohol and THC combinations, which is the most clinically relevant question. Simulated driving doesn’t perfectly predict real-world crash risk, and the study doesn’t report actual safety events or ecological validity measures. Finally, the abstract cuts off mid-sentence on a key finding, making complete assessment impossible.
Dr. Caplan’s Take
This is useful controlled data in a space where we’ve mostly had anecdotes and animal models. The equivalence between moderate alcohol and moderate THC for driving impairment is a noteworthy finding that clinicians can cite when patients ask for specifics. However, I’m cautious about over-interpreting the sample (young, self-selected for co-use experience) and the gap between a driving simulator and real roads with traffic, weather, and fatigue. What matters most for my patient conversations is this: we now have evidence that mixing these substances adds risk in measurable ways, and the risk appears dose-dependent for THC.
Clinical Bottom Line
Counsel patients that combining cannabis edibles with alcohol impairs simulated driving in ways that are dose-dependent and appear additive or worse. This is the clearest controlled evidence yet for a conversation about co-use risks, but it comes from a young, experienced co-user population and a simulator setting.
| |
Have thoughts on this? Share it:
